4.7 Review

CRISPR/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects

期刊

MOLECULAR THERAPY-NUCLEIC ACIDS
卷 9, 期 -, 页码 230-241

出版社

CELL PRESS
DOI: 10.1016/j.omtn.2017.09.009

关键词

-

资金

  1. NSFC [31270967, 31571407]
  2. Shenzhen seed grant [JCYJ20140828163633995]
  3. Hong Kong TRS [T12-708/12-N]
  4. Hong Kong RGC GRF [HKU17113816, HKU17120517]

向作者/读者索取更多资源

Genome-editing involves the insertion, deletion, or replacement of DNA in the genome of a living organism using molecular scissors. Traditional genome editing with engineered nucleases for human stem cells is limited by its low efficiency, high cost, and poor specificity. The CRISPR system has recently emerged as a powerful gene manipulation technique with advantages of high editing efficiency and low cost. Although this technique offers huge potential for gene manipulation in various organisms ranging from prokaryotes to higher mammals, there remain many challenges in human stem cell research. In this review, we highlight the basic biology and application of the CRISPR/Cas9 system in current human stem cell research, discuss its advantages and challenges, and debate the future prospects for human stem cells in regenerative medicine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据